Drugs / Plasmalyte Viaflo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03630224 | Jun 2019 → Aug 2023 | acute kidney injury | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plasmalyte Viaflo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03630224 ↗ |